Search
Capricor Therapeutics Inc
CAPRAdd to Watchlist
11.220USD
+2.350+26.49%
Close 11-11 16:00（ET）
652.33MMarket Cap
LossP/E TTM
After-hours 19:58 (ET)11.050USD-0.155-1.38%
After-hours 19:58 (ET)Today
+26.49%
5 Days
+25.78%
1 Month
+43.30%
6 Months
-64.83%
Year to Date
-61.12%
1 Year
+80.97%
Key Figures
9.650Open
11.230High
869.49KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
1.50%Turnover Ratio
8.870Prev. Close
8.980Low
9.08MTurnover
LossP/E Static
2.65P/B
0.00%Div Yield TTM
-47.74%ROA
40.37052wk High
0.17Volume Ratio
-40.47MNet Profit
58.14MShares
-2.3165EPS TTM
0.40Beta
-56.40%ROE
2.96052wk Low
26.83%Amplitude
100.00%Gross Margin
652.33MMarket Cap
-12.17Reward/Risk
24.93%Risk Rate
Capricor Therapeutics Inc's Score
0.17vs previous score
Forecast7.00
Financial Health5.67
Technical7.07
Valuation Dimensions6.82
Institutional Confidence5.00
Risk Assessment2.11
Media Coverage
Coverage Level
Very Low
Very High
Negative-
Analyst Rating
Capricor Therapeutics Inc Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy
Capricor Therapeutics Inc Latest Earnings Call Transcripts
Capricor Therapeutics (CAPR) Q2 2026 Earnings Call: Deramocel BLA Path and FDA Update
Capricor Therapeutics’ Q2 2026 earnings call covered its deramocel BLA amendment plan, $237.9 million cash balance and $40.7 million net loss.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.73/-0.43
Revenue / Forecast
--/41.71M
Capricor Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolCAPR
Number of employees160
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Nippon Shinyaku Co Ltd | 8.55% |
| Suvretta Capital Management, LLC | 5.91% |
| Tang Capital Management, LLC | 5.88% |
| BlackRock Institutional Trust Company, N.A. | 4.51% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 25.82% |
| Investment Advisor | 15.86% |
| Corporation | 8.55% |
| Investment Advisor/Hedge Fund | 8.33% |
Related Instruments
+0.35%
-0.13%
+0.37%
-0.59%
-1.80%
-0.69%
+0.62%
-0.67%
+0.96%
+0.31%
-0.16%
+0.18%
-0.26%
+0.41%
-1.23%
-0.85%
+4.73%
-0.43%
+0.24%
+0.62%
FAQs
What is the current price of Capricor Therapeutics Inc (CAPR)?
The current price of Capricor Therapeutics Inc (CAPR) is 11.22.
What is the symbol of Capricor Therapeutics Inc?
The ticker symbol of Capricor Therapeutics Inc is CAPR.
What is the 52-week high of Capricor Therapeutics Inc?
The 52-week high of Capricor Therapeutics Inc is 40.37.
What is the 52-week low of Capricor Therapeutics Inc?
The 52-week low of Capricor Therapeutics Inc is 2.96.
What is the market capitalization of Capricor Therapeutics Inc?
The market capitalization of Capricor Therapeutics Inc is 652.33M.
Is Capricor Therapeutics Inc (CAPR) currently rated as Buy, Hold, or Sell?
According to analysts, Capricor Therapeutics Inc (CAPR) has an overall rating of Buy, with a price target of 23.67.
What is the Earnings Per Share (EPS TTM) of Capricor Therapeutics Inc (CAPR)?
The Earnings Per Share (EPS TTM) of Capricor Therapeutics Inc (CAPR) is -2.32.